Matches in SemOpenAlex for { <https://semopenalex.org/work/W2167994086> ?p ?o ?g. }
- W2167994086 abstract "To evaluate the polysomnographic efficacy and the safety of a range of doses of eszopiclone relative to placebo in patients with primary insomnia. Zolpidem 10 mg was included as an active control.This multicenter, randomized, crossover study enrolled patients aged 21-64 years meeting the DSM-IV criteria for primary insomnia (n = 65). Patients received 2 nights treatment each with placebo, eszopiclone 1 mg, 2 mg, 2.5 mg, or 3 mg, and zolpidem 10 mg after randomization to one of 6 treatment sequences. Visits were separated by a 3-7 day washout. Objective efficacy was assessed by polysomnography (PSG). The primary endpoint was latency to persistent sleep (LPS); key secondary endpoints were sleep efficiency (SE) and wake time after sleep onset (WASO); other endpoints included wake time during sleep (WTDS) and number of awakenings (NAW), as well as patient-reported variables.LPS and SE were significantly different than placebo for all active treatments (p < 0.05 for all). Significant differences from placebo were noted in the 3 objective sleep maintenance measures (WASO, WTDS, and NAW) for eszopiclone 3 mg (p < 0.05), which was not the case for zolpidem 10 mg or the other eszopiclone doses. The incidence of central nervous system adverse events was 23.4% for zolpidem 10 mg, 6.2% to 12.5% for the eszopiclone doses, and 7.9% for placebo.Relative to placebo, all active treatments were effective in reducing LPS and increasing SE. Eszopiclone 3 mg was significantly different from placebo on the 3 PSG measures of sleep maintenance (WASO, WTDS, and NAW). Significant differences between zolpidem 10 mg and eszopiclone (2 mg or 3 mg) were not observed for PSG-measured outcomes, although the study was not powered to detect differences between the active drug conditions." @default.
- W2167994086 created "2016-06-24" @default.
- W2167994086 creator A5016898204 @default.
- W2167994086 creator A5020024835 @default.
- W2167994086 creator A5053410578 @default.
- W2167994086 creator A5058012375 @default.
- W2167994086 creator A5060017251 @default.
- W2167994086 creator A5064903239 @default.
- W2167994086 creator A5079115182 @default.
- W2167994086 creator A5086521979 @default.
- W2167994086 date "2008-06-15" @default.
- W2167994086 modified "2023-09-24" @default.
- W2167994086 title "A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia." @default.
- W2167994086 cites W1273834102 @default.
- W2167994086 cites W1693832253 @default.
- W2167994086 cites W1762892354 @default.
- W2167994086 cites W1791726371 @default.
- W2167994086 cites W1969419378 @default.
- W2167994086 cites W1977894152 @default.
- W2167994086 cites W1978392134 @default.
- W2167994086 cites W2000979605 @default.
- W2167994086 cites W2083942987 @default.
- W2167994086 cites W2091908519 @default.
- W2167994086 cites W2099661804 @default.
- W2167994086 cites W2127024218 @default.
- W2167994086 cites W2138362387 @default.
- W2167994086 cites W2147612834 @default.
- W2167994086 cites W2163075338 @default.
- W2167994086 cites W2271655684 @default.
- W2167994086 cites W2324394935 @default.
- W2167994086 cites W2328096072 @default.
- W2167994086 cites W2416055588 @default.
- W2167994086 cites W2975185535 @default.
- W2167994086 cites W3022302886 @default.
- W2167994086 cites W49841469 @default.
- W2167994086 cites W49933285 @default.
- W2167994086 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2546455" @default.
- W2167994086 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18595435" @default.
- W2167994086 hasPublicationYear "2008" @default.
- W2167994086 type Work @default.
- W2167994086 sameAs 2167994086 @default.
- W2167994086 citedByCount "9" @default.
- W2167994086 countsByYear W21679940862015 @default.
- W2167994086 countsByYear W21679940862017 @default.
- W2167994086 countsByYear W21679940862018 @default.
- W2167994086 crossrefType "journal-article" @default.
- W2167994086 hasAuthorship W2167994086A5016898204 @default.
- W2167994086 hasAuthorship W2167994086A5020024835 @default.
- W2167994086 hasAuthorship W2167994086A5053410578 @default.
- W2167994086 hasAuthorship W2167994086A5058012375 @default.
- W2167994086 hasAuthorship W2167994086A5060017251 @default.
- W2167994086 hasAuthorship W2167994086A5064903239 @default.
- W2167994086 hasAuthorship W2167994086A5079115182 @default.
- W2167994086 hasAuthorship W2167994086A5086521979 @default.
- W2167994086 hasConcept C118552586 @default.
- W2167994086 hasConcept C126322002 @default.
- W2167994086 hasConcept C142724271 @default.
- W2167994086 hasConcept C1513209611 @default.
- W2167994086 hasConcept C197934379 @default.
- W2167994086 hasConcept C204787440 @default.
- W2167994086 hasConcept C27081682 @default.
- W2167994086 hasConcept C2777123777 @default.
- W2167994086 hasConcept C2778205975 @default.
- W2167994086 hasConcept C2781210498 @default.
- W2167994086 hasConcept C2781326671 @default.
- W2167994086 hasConcept C2910380747 @default.
- W2167994086 hasConcept C3018359032 @default.
- W2167994086 hasConcept C42219234 @default.
- W2167994086 hasConcept C71924100 @default.
- W2167994086 hasConceptScore W2167994086C118552586 @default.
- W2167994086 hasConceptScore W2167994086C126322002 @default.
- W2167994086 hasConceptScore W2167994086C142724271 @default.
- W2167994086 hasConceptScore W2167994086C1513209611 @default.
- W2167994086 hasConceptScore W2167994086C197934379 @default.
- W2167994086 hasConceptScore W2167994086C204787440 @default.
- W2167994086 hasConceptScore W2167994086C27081682 @default.
- W2167994086 hasConceptScore W2167994086C2777123777 @default.
- W2167994086 hasConceptScore W2167994086C2778205975 @default.
- W2167994086 hasConceptScore W2167994086C2781210498 @default.
- W2167994086 hasConceptScore W2167994086C2781326671 @default.
- W2167994086 hasConceptScore W2167994086C2910380747 @default.
- W2167994086 hasConceptScore W2167994086C3018359032 @default.
- W2167994086 hasConceptScore W2167994086C42219234 @default.
- W2167994086 hasConceptScore W2167994086C71924100 @default.
- W2167994086 hasLocation W21679940861 @default.
- W2167994086 hasOpenAccess W2167994086 @default.
- W2167994086 hasPrimaryLocation W21679940861 @default.
- W2167994086 hasRelatedWork W1545689369 @default.
- W2167994086 hasRelatedWork W1762892354 @default.
- W2167994086 hasRelatedWork W187579988 @default.
- W2167994086 hasRelatedWork W1977894152 @default.
- W2167994086 hasRelatedWork W2000979605 @default.
- W2167994086 hasRelatedWork W2037926687 @default.
- W2167994086 hasRelatedWork W2051392321 @default.
- W2167994086 hasRelatedWork W2066580767 @default.
- W2167994086 hasRelatedWork W2066588666 @default.
- W2167994086 hasRelatedWork W2091908519 @default.
- W2167994086 hasRelatedWork W2099661804 @default.
- W2167994086 hasRelatedWork W2119644947 @default.
- W2167994086 hasRelatedWork W2127024218 @default.